Clinical Trial Update: Long-Term Effects of Sublingual Grass Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the long-term safety and effects of sublingual grass pollen immunotherapy for seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Sublingual grass pollen extract (grass pollen extract)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Rhinitis, Allergic, Seasonal | Phase 2 | Status: COMPLETED